key: cord-0784748-427wqyd8
authors: Cosentino, Nicola; Marenzi, Giancarlo; Chiesa, Mattia
title: The Impact of COVID-19 Pandemic on Scientific Research: an Upcoming New Wave?
date: 2022-05-23
journal: J Gen Intern Med
DOI: 10.1007/s11606-022-07647-6
sha: c7a892e5b165aa6483f0ec77a7e06e37822f3738
doc_id: 784748
cord_uid: 427wqyd8

The coronavirus disease (COVID)-19 pandemic continues to have an impact on health care. A potential new wave can be foreseen concerning the impact of the pandemic on medical research and literature. We focused our attention on journals belonging to “Medicine, General and Internal” Clarivate™ category and “Q1” journal impact factor quartile. We found that since January 2020, 9621 papers regarding COVID-19 have been published in these journals. This occurred at the expense of non-COVID-19-related scientific papers as most journals did not increase the total number of their published articles. Thus, our analysis may outlook a new potential scientific wave related to COVID-19, in addition to the clinical ones, possibly delaying the improvement in the quality of care for other diseases in the next years.

T he novel coronavirus disease (COVID)-19 pandemic has had and still continues to have an extraordinary impact on health care. 1 Different types of the effects of the pandemic over the short-, medium-, and long-term periods have been interestingly depicted, and four different waves associated with COVID-19 have been identified. These address the immediate response to COVID-19 outbreak and pandemic, the postponing of other urgent health conditions, the interruption of the care of chronic conditions, and the psychological trauma caused within the broader population, respectively. 2 However, a potential fifth wave of COVID-19 can be foreseen concerning the impact of the pandemic on the entire world of medical science. Indeed, over the past 2 years, the attention of physicians, researchers, and scientific journals has been partially and legitimately directed to the pandemic. This might occur at the expense of scientific research in other clinical settings of similar prevalence and relevance. The ultimate and most important role of medical journals is to advance scientific knowledge and impact on patient care. This is particularly true for high-impact-factor journals, which largely influence the community of scientists, clinical guidelines, and hence, daily clinical practice. 3 In order to explore the impact of COVID-19-related publications, we focused our attention on journals belonging to "Medicine, General and Internal" Clarivate™ category and "Q1" journal impact factor quartile. We exploited Pubmed® to extract papers published from January 1, 2018, to December 31, 2021, specifying those related to COVID-19 (adding "COVID-19" OR "Coronavirus" OR "SARS-CoV-2" as search criteria) for each journal. Then, we used histograms, box-and-dots plots, density plots, and correlation plots to assess the number of COVID-19 reports on journal publication rate. Analysis and plots were performed using the "R" statistical environment.

Since January 2020, an overwhelming number (n = 9962) of papers focusing on COVID-19 has been published in the considered Q1 General and Internal Medicine journals (Fig. 1A) . Notably, the percentage of papers regarding COVID-19 ranged approximately between 10 and 50% of the total number of publications (Fig. 1B) . It occurred at the expense of non-COVID-19-related scientific papers, as most of these journals did not increase the total number of their published articles ( Fig. 2A) . Interestingly, the higher was the impact factor of the journal, the greater was the percentage of articles on COVID-19 (Fig. 2B) .

We fully acknowledge the crucial role of the scientific production on COVID-19 in helping health personnel and scientists in the management of this disease, especially with the frontline experiences being very precious. However, the high percentages of papers dedicated to COVID-19 on highranking medical journals considered in our analysis may outlook a new potential scientific wave paralleling the clinical one. In other words, just as clinical care has been largely devoted to COVID-19 and the management of other pathologies has been partially neglected, so too medical journals have prioritized COVID-19, significantly slowing down the publication of non-COVID-19-related studies. However, it cannot be excluded that some of the non-COVID-19 research articles were published in other scientific journals with lower impact or from other fields. Moreover, all the efforts dedicated to the research on COVID-19 has been partially subtracted from investigations focusing on other clinical and basic science settings. Interestingly, a recent study noted that by May 2020, ClinicalTrials.gov had registered more than 1200 COVID-19related trials. 4 As clinical guidelines are mainly based on studies published in high-impact-factor journals, it can be hypothesized that in the next years there will be a slowdown in updating the guidelines. Therefore, a potential delay in the improvement in the quality of care for major diseases could occur. Our preliminary observations, as well as other recent evidence, 5, 6 rather than being a systematic analysis of all the scientific works published during the pandemic, are intended to be a message of attention to a possible future scenario. Although further confirmation is needed about a possible adverse scientific wave, the experience gained during the COVID-19 pandemic should be an instructive lesson to help us be "better prepared" and "optimize" scientific research and diffusion also when the health-care system is under extreme strain.

Covid-19 and the safety net -moving from straining to sustaining

The COVID-19 pandemic presents an opportunity to develop more sustainable health workforces

Record high EHJ Impact Factor 2016

The carnage of substandard research during the COVID-19 pandemic: a call for quality

Impact of the COVID-19 pandemic on publication dynamics and non-COVID-19 research production

Publication non grata: the challenge of publishing non-COVID-19 research in the COVID era

Author Contribution Dr. Marenzi, Dr. Cosentino, and Dr. Chiesa had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Study concept and design: Cosentino and Chiesa; acquisition of the data: Chiesa; analysis and interpretation of the data: Marenzi, Cosentino, and Chiesa; drafting of the manuscript: Cosentino and Chiesa; critical revision of the manuscript for important intellectual content: Marenzi; statistical analysis: Chiesa; administrative, technical, or material support: Chiesa; study supervision: Marenzi.

Conflict of Interest: The authors declare that they do not have a conflict of interest.Disclosures: None.